Scientists devise a barcode for the bacteria that causes tuberculosis

Doctors and researchers will be able to easily identify different types of tuberculosis (TB) thanks to a new genetic barcode devised by scientists from the School September 1, 2014 The bacteria that cause the deadly respiratory disease have evolved into families of strains, or lineages, which may affect people differently. To help identify the different origins and map how tuberculosis …

New Vaccine Provides Greater Protection than BCG Against Both Tuberculosis and Leprosy

Research headed by UCLA has found that a variation of the BCG vaccine offers stronger protection against the diseases Both tuberculosis and leprosy often occur together, and leprosy usually only occurs in places where tuberculosis occurs. Most infants are vaccinated against the two diseases with the Bacille Calmette-Guerin vaccination, which has been used for over a century now. However this …

MBio Diagnostics Presents Tuberculosis Study Results

MBio Diagnostics presents “Highly Multiplexed Detection of Antibodies in Whole Blood during Tuberculosis Infection” study results. March 11, 2014 MBio Diagnostics, Inc. presented results last week of a study entitled “Highly Multiplexed Detection of Antibodies in Whole Blood during Tuberculosis Infection” at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, MA. MBio is collaborating with the Foundation for …

Researchers to examine whether BCG vaccine combats allergies

Researchers in Australia are about to embark on a trial examining whether the BCG vaccine against TB could also protect against allergic sensitization. The BCG vaccine was phased out of the the Australian immunization schedule three decade ago, and in recent years the country has experienced skyrocketing allergy rates. Melbourne researchers hypothesize that the two could be linked, and will …

Tuberculosis: A Devastating Disease

Tuberculosis: A Devastating Disease WHO declared the devastating affects Tuberculosis a global health emergency. With over 2 billion people or 1/3 of the world's population infected with the TB bacillus and 8.8 million new cases and 1.4 million deaths per year, the numbers clearly explain why. TB is the leading cause of death for people living with HIV in Africa. …

2020 vision for vaccines against HIV, tuberculosis and malaria

Rino Rappuoli, PhD, is Global Head of Vaccines Research at Novartis Vaccines and Diagnostics and is based in Siena, Italy.   In one of his most recent publications in Nature together with Alan Aderem, they discuss their 2020 vision for vaccines against HIV, tuberculosis and malaria.   Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five …